Literature DB >> 23026274

Diagnosis and management of Barrett's esophagus.

Eric M Nelsen1, Robert H Hawes, Prasad G Iyer.   

Abstract

Barrett esophagus is characterized by the replacement of squamous mucosa in the esophagus by specialized intestinal metaplasia. Its clinical significance lies in it being the strongest risk factor for and known precursor for esophageal adenocarcinoma. Diagnosis requires endoscopic confirmation of columnar metaplasia in the distal esophagus and histologic confirmation of specialized intestinal metaplasia. Recommendations for the management of subjects diagnosed with Barrett esophagus include periodic endoscopic surveillance to detect the development of high-grade dysplasia or adenocarcinoma. Careful endoscopic evaluation with high-resolution endoscopy and endoscopic resection is recommended in the evaluation of subjects with high-grade dysplasia and early adenocarcinoma.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23026274      PMCID: PMC3727425          DOI: 10.1016/j.suc.2012.07.009

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  117 in total

1.  Hospital volume and hospital mortality for esophagectomy.

Authors:  J J van Lanschot; J B Hulscher; C J Buskens; H W Tilanus; F J ten Kate; H Obertop
Journal:  Cancer       Date:  2001-04-15       Impact factor: 6.860

2.  Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study.

Authors:  R E Sampliner; D Faigel; M B Fennerty; D Lieberman; A Ippoliti; K Lewin; W M Weinstein
Journal:  Gastrointest Endosc       Date:  2001-05       Impact factor: 9.427

3.  The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence.

Authors:  Heiko Pohl; H Gilbert Welch
Journal:  J Natl Cancer Inst       Date:  2005-01-19       Impact factor: 13.506

4.  p53 expression in low grade dysplasia in Barrett's esophagus: correlation with interobserver agreement and disease progression.

Authors:  Marek Skacel; Robert E Petras; Lisa A Rybicki; Terry L Gramlich; Joel E Richter; Gary W Falk; John R Goldblum
Journal:  Am J Gastroenterol       Date:  2002-10       Impact factor: 10.864

5.  Incidence of adenocarcinoma among patients with Barrett's esophagus.

Authors:  Frederik Hvid-Jensen; Lars Pedersen; Asbjørn Mohr Drewes; Henrik Toft Sørensen; Peter Funch-Jensen
Journal:  N Engl J Med       Date:  2011-10-13       Impact factor: 91.245

6.  Circumferential and focal ablation of Barrett's esophagus containing dysplasia.

Authors:  Virender K Sharma; H Jae Kim; Ananya Das; Christopher D Wells; Cuong C Nguyen; David E Fleischer
Journal:  Am J Gastroenterol       Date:  2009-01-27       Impact factor: 10.864

Review 7.  A cost-utility analysis of ablative therapy for Barrett's esophagus.

Authors:  John M Inadomi; Ma Somsouk; Ryan D Madanick; Jennifer P Thomas; Nicholas J Shaheen
Journal:  Gastroenterology       Date:  2009-03-06       Impact factor: 22.682

8.  Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus.

Authors:  D A Katzka; D O Castell
Journal:  Am J Gastroenterol       Date:  1994-07       Impact factor: 10.864

9.  Abdominal obesity and body mass index as risk factors for Barrett's esophagus.

Authors:  Douglas A Corley; Ai Kubo; Theodore R Levin; Gladys Block; Laurel Habel; Wei Zhao; Pat Leighton; Charles Quesenberry; Greg J Rumore; Patricia A Buffler
Journal:  Gastroenterology       Date:  2007-04-25       Impact factor: 22.682

10.  Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study.

Authors:  Sudarshan R Kadri; Pierre Lao-Sirieix; Maria O'Donovan; Irene Debiram; Madhumita Das; Jane M Blazeby; Jon Emery; Alex Boussioutas; Helen Morris; Fiona M Walter; Paul Pharoah; Richard H Hardwick; Rebecca C Fitzgerald
Journal:  BMJ       Date:  2010-09-10
View more
  4 in total

1.  Balloon catheter-based radiofrequency ablation monitoring in porcine esophagus using optical coherence tomography.

Authors:  William C Y Lo; Néstor Uribe-Patarroyo; Katharina Hoebel; Kathy Beaudette; Martin Villiger; Norman S Nishioka; Benjamin J Vakoc; Brett E Bouma
Journal:  Biomed Opt Express       Date:  2019-03-28       Impact factor: 3.732

2.  Incidence and predictors of osteoporotic fractures in patients with Barrett's oesophagus: a population-based nested case-control study.

Authors:  S Kumar; M T Drake; C D Schleck; M L Johnson; J A Alexander; D A Katzka; P G Iyer
Journal:  Aliment Pharmacol Ther       Date:  2017-10-05       Impact factor: 8.171

Review 3.  Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities.

Authors:  Kyle J Napier; Mary Scheerer; Subhasis Misra
Journal:  World J Gastrointest Oncol       Date:  2014-05-15

Review 4.  Barrett's oesophagus: Current controversies.

Authors:  Chidi Amadi; Piers Gatenby
Journal:  World J Gastroenterol       Date:  2017-07-28       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.